Affimed N.V.

NASDAQ: AFMDHealthcare / Biotechnology / Germany
3.43-0.2000-5.51%Vol 1 190 7521Y Perf -21.84%
Sep 20th, 2019 16:00
BID3.10 ASK3.60
Open3.63 Previous Close3.63
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.67 
Analyst Rating
Strong Buy 1.00
Potencial %
94.46 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★+     41.92
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★+     55.08
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)214 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
35.55 
Earnings Date
6th Nov 2019

Today's Price Range

3.353.68

52wk Range

2.525.08

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
5.86%
1 Month
22.50%
3 Months
0.59%
6 Months
-17.94%
1 Year
-21.84%
3 Years
12.83%
5 Years
-44.50%
10 Years
-

Name / TickerPriceChg.Chg.%
AFMD3.43-0.2000-5.51
AAPL217.73-3.2300-1.46
GOOG1 229.93-8.7800-0.71
MSFT139.44-1.6300-1.16
XOM72.08-0.2500-0.35
WFC48.63-0.2800-0.57
JNJ131.651.54001.18
FB189.93-0.2100-0.11
GE9.37-0.0500-0.53
JPM118.90-0.4800-0.40
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.16-0.160.00
Q01 2019-0.160.03118.75
Q04 2018-0.170.17200.00
Q03 2018-0.17-0.22-29.41
Q02 2018-0.17-0.165.88
Q01 2018-0.18-0.180.00
Q04 2017-0.16-0.160.00
Q03 2017-0.21-0.210.00
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.1417.65Positive
12/2019 QR0.191 800.00Positive
12/2019 FY-0.0871.43Positive
12/2020 FY0.14143.75Positive
Next Report Date6th Nov 2019
Estimated EPS Next Report-0.14
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1 190 752
Shares Outstanding (in ths.)62 390
Trades Count2 722
Dollar Volume2 085 660
Avg. Volume764 484
Avg. Weekly Volume986 629
Avg. Monthly Volume564 387
Avg. Quarterly Volume767 651
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
4 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's own immune defenses to fight tumor cells. It is also developing single and combination therapies to treat cancers and other life-threatening diseases.

CEO: Adi Hoess

Teplephone: +49 6221674360

Address: Technologiepark, Heidelberg 69120, , DEU

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

26%74%

Bearish Bullish

46%54%

Bearish Bullish

51%49%

News